PE/Cyanine7 Anti-Human CD45RA Antibody[HI100]

PE/Cyanine7 Anti-Human CD45RA Antibody[HI100]

Introducing the PE/Cyanine7 Anti-Human CD45RA Antibody [HI100], a cutting-edge product designed to revolutionize immunological research and diagnostics. This antibody, conjugated with PE/Cyanine7, offers exceptional specificity and sensitivity in detecting the CD45RA antigen on human cells.

The PE/Cyanine7 Anti-Human CD45RA Antibody [HI100] is meticulously engineered using advanced techniques, ensuring high purity and consistency. Its superior performance is attributed to the monoclonal antibody HI100, which exhibits remarkable affinity towards the CD45RA antigen, enabling precise identification and characterization of CD45RA-expressing cell populations.

This antibody's PE/Cyanine7 conjugation provides enhanced fluorescence intensity and stability, facilitating accurate and reliable flow cytometry analysis. With its exceptional brightness and minimal spectral overlap, this antibody enables multiplexing experiments, allowing simultaneous detection of multiple markers for comprehensive cellular profiling.

The PE/Cyanine7 Anti-Human CD45RA Antibody [HI100] is an invaluable tool for immunophenotyping studies, immune monitoring, and clinical diagnostics. Its application extends to various research areas, including immunology, oncology, and stem cell research. By enabling the identification and isolation of CD45RA-positive cells, this antibody contributes to a deeper understanding of immune cell subsets and their roles in disease progression and therapeutic response.

We take pride in delivering a product that meets the highest quality standards. The PE/Cyanine7 Anti-Human CD45RA Antibody [HI100] undergoes rigorous quality control measures to ensure batch-to-batch consistency and optimal performance. It is supplied in a convenient format, ready for immediate use in your experiments.

Choose the PE/Cyanine7 Anti-Human CD45RA Antibody [HI100] for its exceptional specificity, sensitivity, and reliability. Empower your research and diagnostics with this state-of-the-art antibody, and unlock new insights into the complex world of immunology.